EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

The High‐Sensitivity C‐Reactive Protein−Albumin−Lymphocyte Index Is a Prognostic Marker for All‐Cause and Cardiovascular Mortality in Patients With ST‐Elevation Myocardial Infarction

Xinuo Ma, Wei Zhang, Ningli Zhang, Qinghua Zhong, Tao Shi, Sirui Yang, Fazhi Yang, Yujuan Peng, Lixing Chen

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70745 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2026. Written by Xinuo Ma and 8 co-authors. Institution: Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China. Major MEDLINE topics: ST Elevation Myocardial Infarction, C-Reactive Protein, Percutaneous Coronary Intervention, Lymphocytes. 49 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Applied Basic Research Program of the Yunnan Province Science and Technology Department and Kunming Medical University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Inflammation and immune dysfunction may worsen the prognosis of patients with ST‐segment elevation myocardial infarction (STEMI).

Aims

This study aimed to assess whether the high‐sensitivity C‐reactive protein–albumin–lymphocyte index (hsCALLYI) could be used to predict the prognosis of STEMI patients who received emergency percutaneous coronary intervention (PCI) treatment.

Methods

Participants were categorized into three groups based on hsCALLYI tertiles. To assess the prognostic significance of hsCALLYI in predicting both all‐cause and cardiovascular mortality, Kaplan–Meier survival curves were constructed, followed by Cox proportional hazards regression modeling and time‐dependent receiver operating characteristic (ROC) curve analysis.

Results

A lower level of hsCALLYI demonstrated a significant correlation with elevated mortality risk from all causes (hazard ratio [HR] = 9.826, 95% CI = 3.091–31.235, p < 0.001) and cardiovascular mortality (HR = 15.035, 95% CI = 3.353–67.408, p < 0.001). The area under the ROC curve of hsCALLYI for all‐cause mortality was 0.696 ( p < 0.05), and the area under the ROC curve of hsCALLYI for cardiovascular mortality was 0.695 ( p < 0.05). Conclusion hsCALLYI emerged as a significant independent prognostic indicator for both all‐cause and cardiovascular mortality in STEMI patients undergoing emergency PCI.

Subjects

MeSH terms (MEDLINE)

ST Elevation Myocardial InfarctionC-Reactive ProteinPercutaneous Coronary InterventionLymphocytesSerum Albumin, HumanHumansMaleFemalePredictive Value of TestsMiddle AgedRisk FactorsAgedBiomarkersTime FactorsROC CurveTreatment OutcomeLymphocyte CountCause of DeathRisk AssessmentKaplan-Meier EstimateProportional Hazards ModelsRetrospective StudiesArea Under Curve

Author keywords

STEMIalbuminhs‐CRPinflammationlymphocytesprognosis

Substances

C-Reactive ProteinBiomarkersSerum Albumin, HumanALB protein, human

Authors and institutions

  • Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Emergency Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Anesthesiology department, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Pediatrics, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

  • Applied Basic Research Program of the Yunnan Province Science and Technology Department and Kunming Medical University

Cite

APA

Ma, X., Zhang, W., Zhang, N., Zhong, Q., Shi, T., Yang, S., Yang, F., Peng, Y., & Chen, L. (2026). The High‐Sensitivity C‐Reactive Protein−Albumin−Lymphocyte Index Is a Prognostic Marker for All‐Cause and Cardiovascular Mortality in Patients With ST‐Elevation Myocardial Infarction. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70745

Vancouver

Ma X, Zhang W, Zhang N, Zhong Q, Shi T, Yang S, et al. The High‐Sensitivity C‐Reactive Protein−Albumin−Lymphocyte Index Is a Prognostic Marker for All‐Cause and Cardiovascular Mortality in Patients With ST‐Elevation Myocardial Infarction. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70745

BibTeX
@article{Ma2026,
  author = {Ma, Xinuo and Zhang, Wei and Zhang, Ningli and Zhong, Qinghua and Shi, Tao and Yang, Sirui and Yang, Fazhi and Peng, Yujuan and Chen, Lixing},
  title = {The High‐Sensitivity C‐Reactive Protein−Albumin−Lymphocyte Index Is a Prognostic Marker for All‐Cause and Cardiovascular Mortality in Patients With ST‐Elevation Myocardial Infarction},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70745}
}
Start for free →